The forecast includes around $6.4 billion in new spending comprised of additional funding for the new five year Community Pharmacy Agreement and new PBS listings. This could equate to between $1.5 and $2 billion in budgeted new spending for 2027-28. Yet the forecast is just $700 million higher than 2023-24. Something else is in there and more is coming. …
The Budget should leave people in no doubt that more announcements are coming
May 15, 2024 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Nurse prescribing reform set to expand access to PBS subsidised medicines
July 3, 2026 - - Latest News -
Cartherics emerges as Asia Pacific leader in off-the-shelf immune cell therapy
July 2, 2026 - - Australian Biotech -
Minister looks to be sending a very clear message about these therapies and the PBS
July 2, 2026 - - Latest News -
The end-game of strong-arming companies over prices at the expense of patients and process
July 2, 2026 - - Latest News -
Commercial outsourcing emerges as a strategic option to patient access
July 1, 2026 - - Latest News -
The minister is following a tried and tested process, but what is the risk in this new world?
July 1, 2026 - - Latest News -
Patient alarm over the potential loss of subsidised access to MS medicines
July 1, 2026 - - Latest News